Utilizing the IVW method, we discovered suggestive evidence indicating that a genetically higher risk of MPN might be associated with increased RANTES levels (β IVW = 0.047, 95% CI: [−0.0003, 0.094],p = 0.051;Fig. 5A). The gene discussed is CCL5; the disease is myeloproliferative neoplasm.